Evidence map›Paper›PMID 27143507›Full record

ArticleScientific reports2016

Gold@silver bimetal nanoparticles/pyramidal silicon 3D substrate with high reproducibility for high-performance SERS.

Chao Zhang, Shou Zhen Jiang, Cheng Yang, Chong Hui Li, Yan Yan Huo, Xiao Yun Liu, Ai Hua Liu, Qin Wei, Sai Sai Gao, Xing Guo Gao and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chao ZhangSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Shou Zhen JiangSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Cheng YangSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Chong Hui LiSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Yan Yan HuoSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Xiao Yun LiuSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Ai Hua LiuSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Qin WeiSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Sai Sai GaoSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.
Xing Guo GaoSchool of Science, Qilu University of Technology, Jinan 250353, China.
Bao Yuan ManSchool of Physics and Electronics, Shandong Normal University, Jinan 250014, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel and efficient surface enhanced Raman scattering (SERS) substrate has been presented based on Gold@silver/pyramidal silicon 3D substrate (Au@Ag/3D-Si). By combining the SERS activity of Ag, the chemical stability of Au and the large field enhancement of 3D-Si, the Au@Ag/3D-Si substrate possesses perfect sensitivity, homogeneity, reproducibility and chemical stability. Using R6G as probe molecule, the SERS results imply that the Au@Ag/3D-Si substrate is superior to the 3D-Si, Ag/3D-Si and Au/3D-Si substrate. We also confirmed these excellent behaviors in theory via a commercial COMSOL software. The corresponding experimental and theoretical results indicate that our proposed Au@Ag/3D-Si substrate is expected to develop new opportunities for label-free SERS detections in biological sensors, biomedical diagnostics and food safety.

Identifiers

PMID27143507
PMCPMC4855179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.